The article, entitled “CLEC-1 is a death sensor that limits antigen cross-presentation by dendritic cells and represents a target for cancer immunotherapy” (2), reports on fundamental discoveries and ...
Hosted on MSN
Study reveals cause of common cancer immunotherapy side effect: How checkpoint inhibitors could improve treatments
A multinational collaboration co-led by the Garvan Institute of Medical Research has uncovered a potential explanation for why some cancer patients receiving a type of immunotherapy called checkpoint ...
TLS’s findings are consistent with recent third-party publications highlighting the unique synergy between BNCT and checkpoint inhibitors. Both independent 2024 studies from Japan reported that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback